MedPath

Cardiovascular Risk in Toledo Population

Conditions
Cardiovascular Risk Factor
Cardiovascular Diseases
Interventions
Other: Observational
Registration Number
NCT03294369
Lead Sponsor
Castilla-La Mancha Health Service
Brief Summary

This epidemiological and observational study is aimed to assess cardiovascular risk (CVR) by investigating the prevalence of CVR factors (CVRF), target organ damage (TOD) and cardiovascular disease (CVD) in general population of the sanitary area of Toledo.

Detailed Description

Epidemiological and observational study that is analyzing a sample from the general population aged 18 years or older, randomly selected from a database of sanitary cards stratified by age and gender.

Clinical history, physical examination and complementary tests are being performed.

Total blood and serum samples are being frozen (-85ºC) for future genetic studies. The biobank is currently being registered at the "Virgen de la Salud" hospital of Toledo.

CVR is assessed by SCORE scale calibrated for Spanish population and the Framingham Heart Study scale.

Patients will be periodically visited, with a minimum follow-up of 5 years. Standard statistical analysis will be performed.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
3125
Inclusion Criteria
  • Subjects aged 18 years or older, randomly selected from a database of health cards stratified by age and gender
Exclusion Criteria
  • Individulas aged under 18 years.
  • Subjects who do not sign the informed consent.
  • Subjects that due to different conditions (physical, mental or social) is expected that do not complete the expected follow-up.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Cohort of the studyObservationalA sample from the general population aged 18 years or older, randomly selected from a database of sanitary cards stratified by age and gender.
Primary Outcome Measures
NameTimeMethod
Assess cardiovascular risk of the study populationDecember 2020

Cardiovascular risk will be determined according to SCORE scale calibrated for Spanish population and the Framingham Heart Study scale.

Prevalence of cardiovascular risk factorsDecember 2020

To assess the prevalence of cardiovascular risk factors

Prevalence of cardiovascular diseaseDecember 2020

To assess the prevalence of cardiovascular disease

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Avenida de Irlanda, 12, 2º A

🇪🇸

Toledo, Spain

© Copyright 2025. All Rights Reserved by MedPath